Ekso Bionics Holdings, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Note 8 - Accrued Liabilities (Tables)

Note 8 - Accrued Liabilities (Tables)

9 Months Ended

Sep. 30, 2023

Notes Tables

Schedule of Accrued Liabilities [Table Text Block]

		*September 30, 2023*				*December 31, 2022*
Salaries, benefits and related expenses		$	1,542			$	1,843
Device warranty			359				274
Other			195				161
Total		$	2,096			$	2,278

Product Maintenance And Warranty [Table Text Block]

		*Three Months Ended*				*Nine Months Ended*
		*September 30, 2023*				*September 30, 2023*
Balance at beginning of period		$	442			$	413
Additions for estimated future costs			91				327
Incurred costs			(75	)			(282	)
Balance at end of period		$	458			$	458

		*Balance as of September 30, 2023*
Current portion		$	359
Long-term portion			99
Total		$	458